14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SNOA vs FEED: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) is the stronger overall head-to-head candidate over FEED (FEED) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SNOA carries a Unified Composite Score of 36.4/100 (SELL) at $0.72 (46.1x Forward P/E, -3.3% operating margin), whereas FEED carries 37.1/100 (SELL) at $1.03 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While FEED currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. SNOA 36.4/100 SELL), SNOA captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.3% vs. N/A operating margin) and revenue trajectory (+28.0% vs. N/A YoY).
Defensive Composite Rating Caution: Although SNOA compares more favorably head-to-head, both SNOA (36.4/100 SELL) and FEED (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: SNOA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1); meanwhile FEED trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNOA vs FEED. Trailing 12-month operating profitability (SNOA -3.3% vs FEED N/A) and valuation multiples (SNOA 46.1x vs FEED N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SNOA vs FEED Key Questions & Quantitative Answers
As of Nov 20, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) is the stronger overall head-to-head candidate over FEED (FEED) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SNOA carries a Unified Composite Score of 36.4/100 (SELL) at $0.72 (46.1x Forward P/E, -3.3% operating margin), whereas FEED carries 37.1/100 (SELL) at $1.03 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While FEED currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. SNOA 36.4/100 SELL), SNOA captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.3% vs. N/A operating margin) and revenue trajectory (+28.0% vs. N/A YoY). Defensive Composite Rating Caution: Although SNOA compares more favorably head-to-head, both SNOA (36.4/100 SELL) and FEED (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: SNOA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1); meanwhile FEED trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SNOA leads the Growth & Scale pillar: SNOA posts +28.0% YoY revenue growth and +0.0% YoY earnings growth on $23M TTM revenue (39.2% gross margin, -3.3% operating margin), compared with FEED at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SNOA generates $23M in USD-normalized revenue versus N/A for FEED. In operating R&D and SG&A reinvestment, SNOA deploys 42.5% of Rev ($10.0M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FEED.
SNOA screens cheaper on headline valuation multiples. SNOA trades at 46.1x Forward P/E, 46.1x Trailing P/E, 1.08x PEG, and 0.1x EV/Revenue (-17.6% FCF margin), whereas FEED trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNOA (-34.5% ROE) versus FEED (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, SNOA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.59β · 92% Vol realized risk). By comparison, FEED carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-6.40β · 3942% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.